The intensity of COL5A1-positive staining was increased in patients with GBM (G4) and G3 glioma (G3) compared to that in patients with G1 and G2 gliomas (G1, G2) (Figure 6b). The gene discussed is COL5A1; the disease is central nervous system cancer.